Cost Analysis

Didik Setiawan, PhD., Apt

- Faculty of Pharmacy,
- Center for Health Economic Studies,
Universitas Muhammadiyah Purwokerto, Purwokerto, Indonesia

Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP
farmasi.ump.ac.id
farmasi.ump.ac.id
 Economic evaluation

Cost only Outcome only Both cost and

outcome
No comparison Cost description Outcome Cost and
description outcome
description
With comparison Cost analysis Efficacy or CEA
effectiveness CUA
evaluation CBA
CMA

Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP
farmasi.ump.ac.id
farmasi.ump.ac.id
 Types of Economic Evaluation

input outcome Result

Cost Effectiveness monetary Different magnitude of a common Cost per unit of consequences. Eg.
Analysis (CEA) measure. E.g. life year gain, blood Cost per LYG
glucose reduction
Cost Utility Analysis monetary Single or multiple effects (not Cost per unit of consequences. Eg.
(CUA) necessarily common). Valued as Cost per QALYs
‘utility’. Eg. QALYs
Cost Benefit Analysis monetary As for CEA but valued as money Net cost or cost benefit ratio
(CBA)
Cost Minimization monetary Considered equal Least cost alternative
Analysis (CMA)

Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP
farmasi.ump.ac.id
farmasi.ump.ac.id
 Cost Effectiveness Analysis

Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP
farmasi.ump.ac.id
 Cost Effectiveness Analysis

Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP
farmasi.ump.ac.id
farmasi.ump.ac.id
Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP
farmasi.ump.ac.id
farmasi.ump.ac.id
 Cost Data

Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP
farmasi.ump.ac.id
farmasi.ump.ac.id
 Outcome Research

Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP
farmasi.ump.ac.id
farmasi.ump.ac.id
 QALYs or Utility Data

Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP
farmasi.ump.ac.id
farmasi.ump.ac.id
Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP
farmasi.ump.ac.id
farmasi.ump.ac.id
 Cost Utility analysis

Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP
farmasi.ump.ac.id
farmasi.ump.ac.id
 Cost Benefit Analysis

Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP
farmasi.ump.ac.id
farmasi.ump.ac.id
 Cost Benefit Analysis

Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP
farmasi.ump.ac.id
farmasi.ump.ac.id
 Cost Benefit Analysis

Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP
farmasi.ump.ac.id
farmasi.ump.ac.id
 Cost minimization analysis

Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP
farmasi.ump.ac.id
farmasi.ump.ac.id
 Cost minimization analysis

trials

Simvastatin Atorvastatin

LDL-C <= 110mg/dL LDL-C <= 110mg/dL

maintenance cost maintenance cost

Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP
farmasi.ump.ac.id
farmasi.ump.ac.id
 Discussion
Kerjakan tugas dari Buku Farmakoekonomi Modeling (halaman 24) untuk di bahas
pada pertemuan selanjutnya

Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP
farmasi.ump.ac.id
 Didik Setiawan, PhD., Apt
Email: d.didiksetiawan@gmail.com
Phone (WA): 081 226 700 119
www.ches.ump.ac.id

Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP Fakultas Farmasi UMP
farmasi.ump.ac.id